Academic Journal
CO93 Matching-Adjusted Indirect Treatment Comparison (MAIC) of Teclistamab Versus Selinexor-Dexamethasone for the Treatment of Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)
| العنوان: | CO93 Matching-Adjusted Indirect Treatment Comparison (MAIC) of Teclistamab Versus Selinexor-Dexamethasone for the Treatment of Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM) |
|---|---|
| المؤلفون: | Moreau, P., Usmani, S.Z., van de Donk, N.W.C.J., Garfall, A.L., Delforge, M., Oriol, A., Nooka, A., Rosiñol, L., Bahlis, N., Rodríguez Otero, P., Martin, T., Diels, J., Van Sanden, S., Pei, L., Ammann, E., Chastain, K., Marshall, A., Slavcev, M., Londhe, A., Krishnan, A. |
| المصدر: | Value in Health ; volume 26, issue 12, page S31 ; ISSN 1098-3015 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.jval.2023.09.165 |
| الاتاحة: | http://dx.doi.org/10.1016/j.jval.2023.09.165 https://api.elsevier.com/content/article/PII:S1098301523032953?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S1098301523032953?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
| رقم الانضمام: | edsbas.1C9AA8D3 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.jval.2023.09.165 |
|---|